Main Ingredients: Bifidobacterium brevis M-16V

Characteristics: Bifidobacterium brevis M-16V was isolated from the intestines of healthy infants and prepared through inoculation, fermentation culture, concentration, and freeze-drying. This strain has been included in the recommended list of biologics by the European Union's Qualification for Safety (QPS) and in the International Dairy Federation's (IDF) list of microorganisms with a history of safe use in food.

Ingredient Content: Bifidobacterium brevis M-16V: 2 billion CFU/5 drops

Appearance: Liquid

Specification Packaging: Droplet: 15ml/bottle

Usage and Dosage: Take 5 drops once a day each time

Main functions:

1.The organic acid butyric acid secreted by M-16V can bind with fats in the digestive tract, promote fat breakdown and be absorbed by the body, increasing the weight of premature infants and newborns

2. M-16V, isolated from the intestines of healthy infants, with the highest safety (certified by the US FDA)

Mandatory use by NICUs (neonatal intensive care units) in all hospitals in Japan.

3. It can promote the reproduction of bifidobacteria in the intestinal tract of infants, reduce the risk of infection in newborns and premature infants, and promote growth.

4. Effectively improve allergic rhinitis, allergic asthma, reduce the incidence rate of respiratory tract infections caused by viruses and bacteria, and enhance immunity

5. Originating from Morinaga Dairy in Japan, it is used in NICUs of major hospitals in Japan